PTC Therapeutics CFO: 'Positive News on Translarna Just the Start' - Presented by: The Aol. On Network

PTC Therapeutics received a positive opinion from a European regulator in May for its Duchenne muscular dystrophy treatment Translarna and conditional approval in Europe is expected this summer, said the company's CFO Shane Kovacs.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
F $ 13.78 0.62 ▼ 4.31%
PBR $ 12.93 0.82 ▲ 6.77%
MSFT $ 46.13 1.11 ▲ 2.47%
AAPL $ 105.22 0.39 ▲ 0.37%
PBR/A $ 13.46 1.10 ▲ 8.90%
QQQ $ 98.62 0.80 ▲ 0.82%
BAC $ 16.72 0.12 ▲ 0.72%
VALE $ 11.16 0.33 ▲ 3.05%

As of 10/24/2014, 04:15 PM
More Most Active